D. Tang

Reply from the authors [6]

D. Bennett, D. Nordli, J. E. Pina-garza, 2006 .

Oxcarbazepine adjunctive therapy in infants and young children with partial seizures

D. Bennett, D. Nordli, J. E. Pina-garza, 2005, Neurology.

Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis.

R. Jager, G. Francis, A. Reder, 2013, Ophthalmology.

Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy

L. Kappos, G. Francis, P. O'Connor, 2014, Multiple sclerosis.

A randomized, controlled trial of fingolimod (FTY720) in Japanese patients with multiple sclerosis

Y. Itoyama, J. Kira, S. Kikuchi, 2012, Multiple sclerosis.

First-dose effects of fingolimod: Pooled safety data from three phase 3 studies.

Jeffrey A. Cohen, L. Kappos, J. Dimarco, 2014, Multiple sclerosis and related disorders.

Fingolimod reduces the number of severe relapses in patients with relapsing multiple sclerosis: Results from phase III TRANSFORMS and FREEDOMS studies

L. Kappos, H. Hartung, G. Francis, 2011 .